Expression of inducible nitric oxide synthase and p53 in oral epithelial dysplasia

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 90, Issue 5, 2000, Pages 624-629

  Brennan, Peter A ^a,b,c   Conroy, Brian ^a,b   Spedding, Anne V ^a,b  

^a QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

^b ST RICHARD S HOSPITAL   (United Kingdom)

^c Queen Alexandra Hospital ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE SYNTHASE; PROTEIN P53;

ARTICLE; BIOSYNTHESIS; CHEMISTRY; DOWN REGULATION; ENZYME INDUCTION; ENZYMOLOGY; EPITHELIUM CELL; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MOUTH MUCOSA; MOUTH TUMOR; PATHOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRECANCER; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

BLOTTING, WESTERN; DOWN-REGULATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME INDUCTION; EPITHELIAL CELLS; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MOUTH MUCOSA; MOUTH NEOPLASMS; NITRIC OXIDE SYNTHASE; PRECANCEROUS CONDITIONS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034324075     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1067/moe.2000.108800     Document Type: Article

References (28)

1. Lincoln J, Hoyle CHV, Burnstock G. Nitric oxide in health and disease. Biomedical research topics. Cambridge: Cambridge University Press; 1997.
2. Foerstermann U, Kleinert H. Nitric oxide synthase: expression and expressional control of the three isoforms. Naunyn-Schmeideberg's Arch Pharmacol 1995;352:351-64.
3. Kröncke KD, Fehsel K, Kolb-Bachofen V. Inducible nitric oxide synthase and its product nitric oxide, a small molecule with complex biological activities. Biol Chem Hoppe-Seyler 1995;376:327-43.
4. Radomski MW, Jenkins DC, Holmes L, Moncada S. Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets. Cancer Res 1991;51:6073-8.
5. Sherman PA, Laubach VE, Reep BR, Wood ER. Purification and cDNA sequence of an inducible nitric oxide synthase from a tumor cell line. Biochemistry 1993;32:11600-5.
6. 2+/calmodulin-regulated nitric oxide synthases. Cell Calcium 1992;13:427-34.
7. Sagar SM, Singh G, Hodson I, Whitton AC. Nitric oxide and anti-cancer therapy. Cancer Treat Rev 1995;21:159-81.
8. Wink DA, Vodovotz Y, Laval D, Laval F, Dewhirst DW, Mitchell JB. The multifaceted roles of nitric oxide in cancer. Carcinogenesis 1998;19:711-21.
9. Rosbe KW, Prazma J, Petrusz P, Mims W, Ball SS, Weissler MC. Immunohistochemical characterization of nitric oxide synthase activity in squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg 1995;113:541-9.
10. Gavilanes J, Moro MA, Lizasoain I, Lorenzo P, Pérez A, Leza JC, et al. Nitric oxide synthase activity in human squamous cell carcinoma of the head and neck. Laryngoscope 1999;109:148-52.
11. Gallo O, Masini E, Morbidelli L, Franchi A, Fini-Storchi I, Vergari WA, et al. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst 1998;90:587-96.
12. Ambs S, Hussain SP, Harris CC. Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. Fed Am Soc Exp Biol J 1997;11:443-8.
13. Ambs S, Ogunfusika MO, Merriam WG, Bennet WP, Billiar TR, Harris CC. Up-regulation of inducible nitric oxide synthase expression in cancer-prone p53 knockout mice. Proc Natl Acad Sci U S A 1998;95:8823-8.
14. Ogden GR, Kiddie RA, Lunny DP, Lane DP. Assessment of p53 protein expression in normal, benign and malignant oral mucosa. J Pathol 1992;166:389-94.
15. Field JK, Spandidos DA, Malliri A, Gosney JR, Yiagnisis M, Stell PM. Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br J Cancer 1991;64:573-7.
16. Shin DM, Kim J, Ro JY, Hittelman J, Roth JA, Hong WA, et al. Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Res 1994;54:321-6.
17. Kerdpon D, Rich AM, Reade PC. Expression of p53 in oral mucosal hyperplasia, dysplasia and squamous cell carcinoma. Oral Dis 1997;3:86-92.
18. Wynford-Thomas D. p53 in tumour pathology: can we trust immunocytochemistry? J Pathol 1992;166:329-30.
19. Burkhardt A. Advanced methods in the evaluation of premalignant lesions and carcinomas of the oral mucosa. J Oral Pathol 1985;14:751-78.
20. Brennan PA, Umar T, Buckley J, Zaki GA, Spedding AV, Langdon JD. Nitric oxide synthase expression in pleomorphic adenoma of the parotid. Br J Oral Maxillofac Surg 2000;38:338-42.
21. Bentz B, Haynees GK, Lingen MW, Pelzer HJ, Hanson DG, Radosevich JA. Nitric oxide synthase type 3 is increased in squamous cell hyperplasia, dysplasia, and squamous cell carcinoma of the head and neck. Ann Otol Rhinol Laryngol 1999;108:781-7.
22. Rogers NE, Ignarro LJ. Constitutive nitric oxide synthase from cerebellum is reversibly inhibited by nitric oxide formed from L-arginine. Biochem Biophys Res Comm 1992;189:242-9.
23. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, patholophysiology and pharmacology. Pharmacol Rev 1991;43:109-42.
24. Messmer UK, Ankacrona M, Nicotera P, Brune B. p53 expression in nitric oxide-induced apoptosis. FEBS Lett 1994;355:23-6.
25. Ho YS, Wang YJ, Lin JK. Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells. Mol Carcinog 1996;16:20-31.
26. Forrester K, Ambs S, Lupold SE, Kapust RB, Spillare EA, Weinberg WC, et al. Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase (NOS2) by wild-type p53. Proc Natl Acad Sci U S A 1996;93:2442-7.
27. Hajri A, Metzger E, Vallat F, Coffy S, Flatter E, Evrard S, et al. Role of nitric oxide in pancreatic tumour growth: in vivo and in vitro studies. Br J Cancer 1998;78:841-9.
28. Macmicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997;15:323-50.